MiR-222-3p Promotes Cell Proliferation and Inhibits Apoptosis by Targeting PUMA (BBC3) in Non-Small Cell Lung Cancer.
In conclusion, microRNA-222-3p plays a significant role in the regulation of Bcl-2-binding component 3 expression and might be a promising target for clinical non-small cell lung cancer therapy.
PMID: 32588752 [PubMed - in process]
Source: Technology in Cancer Research and Treatment - Category: Cancer & Oncology Authors: Chen W, Li X Tags: Technol Cancer Res Treat Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Study